Tracked deals
7
7 tracked deals across 2023-2026.
Waltham, Massachusetts, United States
Formerly known as Danforth Advisors, Danforth Advisors LLC, Danforth Advisors, LLC
Danforth Health integrates strategy and execution to empower innovation and accelerate value creation for life science companies from discovery through launch, providing cross-functional support across business operations, asset development, regulatory, clinical operations, and commercialization.
Tracked deals
7
7 tracked deals across 2023-2026.
Recent pace
1
1 tracked deal announced in the last 12 months.
Deal mix
Buyout
4 buyout · 3 addon
Last 4 years
Supporting Data
Danforth Health, Inc., a portfolio company of Avesi Partners, acquired Ambit RD, Inc. Ambit is a technology-enabled solutions provider focused on serving rare and specialty biopharma markets with commercial strategy, advanced analytics, and patient identification solutions.
Danforth Advisors, a PE-backed life sciences advisory platform, has acquired PharmaDirections, a virtual drug development partner. The acquisition adds more than 150 specialists and expands Danforth's integrated capabilities across discovery, non-clinical and clinical development, CMC, regulatory strategy, and program and alliance management.
Danforth Advisors, a life-science strategic and operational advisory firm, acquired VPMR, a full-service global market research firm serving life science and healthcare clients. The acquisition expands Danforth’s commercial readiness and market research capabilities; Allison Fuller will remain President of VPMR.
Danforth Advisors has acquired Advyzom, a New Jersey–based regulatory affairs consultancy of approximately 30 specialists, expanding Danforth's clinical and regulatory capabilities to offer a comprehensive suite of services for life science companies. The acquisition integrates Advyzom's regulatory strategy, FDA liaison, medical writing, and submissions expertise into Danforth's platform to better support clients across development, approval, and market entry.
Danforth Advisors has acquired BW Health Group, a commercialization and product-launch services platform serving small- and mid-sized life science companies. The deal adds commercial readiness, launch planning and biopharma marketing capabilities (Benchworks and BW Consulting) to Danforth's integrated life-science advisory and operational services offering.
Danforth Advisors has acquired Elite BioPharma Consulting to expand its Development Strategy & Operations (DS&O) practice, adding clinical development operations, project and trial management, clinical monitoring, program management, regulatory affairs, and medical writing capabilities. The founders of Elite will continue to lead the team as Danforth integrates Elite's expertise into its variable resource model for life science companies.
Danforth Advisors, a provider of outsourced corporate and clinical business functions for the life sciences, has acquired Argot Partners, a strategic communications and investor-relations consultancy focused on life sciences. The acquisition expands Danforth's integrated service offering to include strategic communications; Argot's founders will continue to lead the firm.
Turn tracked acquisition activity into an outreach-ready buyer list.